David Carlander

Oral administration of specific yolk antibodies (IgY) may prevent <i>Pseudomonas aeruginosa</i> infections in patients with cystic fibrosis: A phase I feasibility study

H Kollberg, David Carlander, Hanne Vebert Olesen et al. · Pediatric Pulmonology · 2003 · 123 citations

Medical Microbiology, Microbial Disease, Antibiotics +15

Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress

Stefan Branth, Gunnar Ronquist, Mats Stridsberg et al. · Nutrition Metabolism and Cardiovascular Diseases · 2006 · 71 citations

Obesity, Metabolic Syndrome, Abdominal Fat +8

More Than 10 Years' Continuous Oral Treatment with Specific Immunoglobulin Y for the Prevention of <i>Pseudomonas aeruginosa</i> Infections: A Case Report

Elin Nilsson, H Kollberg, Marie Johannesson et al. · Journal of Medicinal Food · 2007 · 56 citations

Avian IgY antibody : in vitro and in vivo.

David Carlander · KTH Publication Database DiVA (KTH Royal Institute of Technology) · 2002 · 51 citations · Full text

Retention of Specific Yolk IgY in the Human Oral Cavity

David Carlander, H Kollberg, Anders Larsson · BioDrugs · 2002 · 44 citations

Oral Cavity, Specific Yolk Igy, Oral Biology +1